1 option
Guidance on the use of factor V leiden and prothrombin mutation testing in patients with a first unprovoked thromboembolic episode / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author.
- Series:
- CADTH optimal use report ; Volume 4.1B.
- CADTH Optimal Use Report ; Volume 4.1B
- Language:
- English
- Subjects (All):
- Comparative effectiveness review.
- Risk assessment.
- Physical Description:
- 1 online resource (i, 10 pages).
- Place of Publication:
- Ottawa, Ontario : Canadian Agency for Drugs and Technologies in Health, 2015.
- Notes:
- Description based on: online resource; title from PDF information screen (NCBI, viewed October 30, 2022).
- Includes bibliographical references.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.